-transparent.png){kind=logo}
Primary Raynaud's phenomenon (RP) is a relatively common disorder. Most patients with primary RP have only mild symptoms and do not develop complications. Distinguishing primary from secondary RP is important with respect to complications, and for prognosis and treatment. Secondary RP mainly manifests as part of systemic connective tissue disease. About 13% of patients diagnosed initially as having primary RP develop a systemic disorder within the following few years. Both auto-immune serology including antinuclear antibodies (ANA), and capillaroscopy are important diagnostic tools if one suspects the existence or development of a systemic disorder. Calcium antagonists are the cornerstone of RP pharmacotherapy.
Herman M A Hofstee, and
Alexandre E Voskuyl, and
Erik H Serné, and
Yvo M Smulders
November 1991,
Archives des maladies du coeur et des vaisseaux,
Herman M A Hofstee, and
Alexandre E Voskuyl, and
Erik H Serné, and
Yvo M Smulders
January 1975,
Surgery,
Herman M A Hofstee, and
Alexandre E Voskuyl, and
Erik H Serné, and
Yvo M Smulders
October 2007,
La Revue du praticien,
Herman M A Hofstee, and
Alexandre E Voskuyl, and
Erik H Serné, and
Yvo M Smulders
May 2006,
Deutsche medizinische Wochenschrift (1946),
Herman M A Hofstee, and
Alexandre E Voskuyl, and
Erik H Serné, and
Yvo M Smulders
February 2012,
BMJ (Clinical research ed.),
Herman M A Hofstee, and
Alexandre E Voskuyl, and
Erik H Serné, and
Yvo M Smulders
January 1994,
Clinics in dermatology,
Herman M A Hofstee, and
Alexandre E Voskuyl, and
Erik H Serné, and
Yvo M Smulders
February 1993,
European heart journal,
Herman M A Hofstee, and
Alexandre E Voskuyl, and
Erik H Serné, and
Yvo M Smulders
March 1993,
Harefuah,
Herman M A Hofstee, and
Alexandre E Voskuyl, and
Erik H Serné, and
Yvo M Smulders
January 1987,
Annales de dermatologie et de venereologie,
Herman M A Hofstee, and
Alexandre E Voskuyl, and
Erik H Serné, and
Yvo M Smulders
October 2008,
Autoimmunity reviews,
